-------------------------------------------------------------------------
INVESTING ACTIVITIES
Proceeds from maturity of short-term investments 9,500,000 -
Government incentives received on account
of property, plant and equipment 1,834 -
Purchase of property, plant and equipment (198,709) (107,405)
-------------------------------------------------------------------------
Cash used in investing activities 9,303,125 (107,405)
-------------------------------------------------------------------------
FINANCING ACTIVITIES
Proceeds from deferred government incentives 31,264 -
Proceeds from revolving credit facility 4,946,959 4,492,048
Repayment of revolving credit facility (5,098,685) (5,157,528)
Repayment of capital lease obligations (35,159) (32,675)
Repayment of senior and other long-term debt (4,751) (277,266)
-------------------------------------------------------------------------
Cash used in financing activities (160,372) (975,422)
-------------------------------------------------------------------------
Net increase (decrease) in cash and
cash equivalents during the period 6,480,756 (2,501,588)
Cash and cash equivalents,
beginning of period 1,523,597 4,093,293
-------------------------------------------------------------------------
Cash and cash equivalents, end of period 8,004,353 1,591,705
-------------------------------------------------------------------------
-------------------------------------------------------------------------
| SOURCE Bioniche Life Sciences Inc. Copyright©2007 PR Newswire. All rights reserved |